Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with aβ40-positive diffuse plaques in the aged human brain

American Journal of Pathology

Volumn 152, Issue 4, 1998, Pages 983-992

  Funato, Hiromasa ^a,b   Yoshimura, Masahiro ^c   Yamazaki, Tsuneo ^a   Saido, Takaomi C ^d   Ito, Yuji ^e   Yokofujita, Junko ^b,f   Okeda, Riki ^b   Ihara, Yasuo ^a,g  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Tokyo Medical Examiner's Office   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e TOHO UNIVERSITY   (Japan)

^f TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SENILE PLAQUE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ASTROCYTES; BRAIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH INHIBITORS; HUMANS; LIPOFUSCIN; MICROSCOPY, ELECTRON; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; S100 PROTEINS; SENILE PLAQUES;

EID: 0031922062     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 1994, 13:45-53
2. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y: Amyloid β-protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down's syndrome. Ann Neurol 1995, 37:294-299
3. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y: Amyloid β-proteins (Aβ)1-40, and 1-42(43) in the soluble fraction of extra-and intracranial blood vessels. Ann Neurol 1995, 38:421-428
4. Wisniewski HM, Weigel J: Migration of perivascular cells into the neuropil and their involvement in β-amyloid plaque formation. Acta Neuropathol (Berl) 1993, 85:586-595
5. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD: Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 1996, 382:716-719
6. Paresce DM, Ghosh RN, Maxfield FR: Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 1996, 17:553-565
7. Masters CL, Simms G, Weinman A, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985, 82:4245-4249
8. Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG: Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein. Proc Natl Acad Sci USA 1992, 89:7437-7441
9. Nordstedt C, Naslund J, Tjernberg LO, Karlstrom AR, Thyberg J, Terenius L: The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem 1994, 269:30773-30776
10. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RCA, Younkin SG, Brunden KR: Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol Aging 1995, 16:737-745
11. Boland K, Behrens M, Choi D, Manias K, Perlmutter DH: The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide. J Biol Chem 1996, 271:18032-18044
12. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM: RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691
13. Qiu WQ, Borth W, Ye Z, Haass C, Teplow DB, Selkoe DJ: Degradation of amyloid β-protein by a serine protease-α2-macroglobulin complex. J Biol Chem 1996, 271:8443-8451
14. Naidu A, Quon D, Cordell B: β-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. J Biol Chem 1995, 270:1369-1374
15. Mirra SS, Heyman A, McKee D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, participating CERAD neuropathologists: the consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 42:1681-1689
16. Tierney MC, Fisher H, Lewis AJ: The NICDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: clinicopathological study of 57 cases. Neurology 1988, 38:356-364
17. Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N: Long amyloid β-protein secreted from wild-type human neuroblastoma IMR-32 cells Biochemistry 1995, 34:10272-10278
18. Yanagisawa K, Odaka A, Suzuki N, Ihara Y: GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nature Med 1995, 1:1062-1066
19. Kim KS, Miller DL, Sapienza VJ, Chen CMJ, Bai C, Grundke-Iqbal I, Currie JR, Wisniewski HM: Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 1988, 2:121-130
20. Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S: Amino-and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain. Neurosci Lett 1996, 215:173-176
21. Iwatsubo T, Saido TC, Mann DMA, Lee VM-Y, Trojanowski JQ: Full-length amyloid-β (1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques. Am J Pathol 1996, 149:1823-1830
22. Yamaguchi H, Morimatsu M, Hirai S, Takahashi K: Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages. Acta Neuropathol 1987, 72:214-217
23. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M: The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991, 7:337-347
24. Hozumi I, Inuzuka T, Hiraiwa M, Uchida Y, Anezaki T, Ishiguro H, Kobayashi H, Uda Y, Miyatake T, Tsuji S: Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds: an immunocytochemical study using confocal laser scan microscope. Brain Res 1995, 688:143-148
25. Grundke-Iqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG: Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl) 1990, 81:105-110
26. Mannoji H, Yeger H, Becker LE: A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia and application to routine histopathology. Acta Neuropathol (Berl) 1986, 71:341-343
27. Shin RW, Iwaki T, Kitamoto T, Tateishi J: Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest 1991, 64:693-702
28. Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, Key G, D'Amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F: Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993, 171:83-98
29. Yamaguchi H, Nakazato Y, Hirai S, Shoji M, Harigaya Y: Electron micrograph of diffuse plaques. Am J Pathol 1989, 135:593-597
30. Yamazaki T, Yamaguchi H, Nakazato Y, Ishiguro K, Kawarabayashi T, Hirai S: Ultrastructural characterization of cerebellar diffuse plaques. J Neuropathol Exp Neurol 1992, 51:281-286
31. Saido TC, Iwatsubo T, Mann DMA, Shimada H, Ihara Y, Kawashima S: Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques. Neuron 1995, 14:457-466
32. Bancher C, Grundke-Iqbal I, Iqbal K, Kim KS, Wisniewski HM: Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid β-protein. Neurobiol Aging 1989, 10:125-132
33. Grundke-Iqbal I, Iqbal K, George L, Tung Y-C, Kim KS, Wisniewski HM: Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:2853-2857
34. Takahashi H, Utsuyama M, Kurashima C, Mori H, Hirokawa K: Monoclonal antibody to β peptide, recognizing amyloid deposits, neuronal cells and lipofuscin pigments in systemic organs. Acta Neuropathol 1993, 85:159-166
35. Stern RA, Otvos L, Trojanowski JQ, Lee VM-Y: Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease β-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am J Pathol 1989, 134:973-978
36. Tamaoka A, Endoh R, Shoji S, Takahashi H, Hirokawa K, Teplow DB, Selkoe DJ, Mori H: Antibodies to amyloid β protein (Aβ) crossreact with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Neurobiol Aging 1996, 17:405-414
37. Stern RA, Trojanowski JQ, Lee VM-Y: Antibodies to the β-amyloid peptide cross-react with conformational epitopes in human fibrinogen subunits from peripheral blood. FEBS Lett 1990, 264:43-47
38. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ: Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992, 357:500-503
39. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG: Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 1992, 255:728-730
40. Ladror US, Snyder SW, Wang GT, Holzman TF, Krafft GA: Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-β by cathepsin D. J Biol Chem 1994, 269:18422-18428
41. Evin G, Cappai R, Li QX, Culvenor JG, Small DH, Beyreuther K, Masters CL: Candidate γ-secretases in the generation of the carboxyl terminus of the Alzheimer's disease β A4 amyloid: possible involvement of cathepsin D. Biochemistry 1995, 34:14185-14192
42. Cataldo AM, Nixon RA: Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA 1990, 87:3861-3865
43. Otsuka N, Tomonaga M, Ikeda K: Rapid appearance of β-amyloid precursor immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res 1991, 568:335-338
44. Saftig P, Peters C, von Figura K, Craessaerts K, Van Leuven F, De Strooper B: Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem 1996, 271:27241-27244
45. Vinores SA, Herman MM: Phagocytosis of myelin by astrocytes in explants of adult rabbit cerebral white matter maintained on Gelfoam matrix. J Neuroimmunol 1993, 43:169-176
46. Dickson DW: The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997, 56:321-339
47. Akiyama H, Kondo H, Mori H, Kametani F, Nishimura T, Ikeda K, Kato M, McGeer PL: The amino-terminally truncated forms of amyloid β-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients. Neurosci Lett 1996, 219:115-118
48. Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, McGeer PL: Granules in glial cells of patients with Alzheimer's disease are immunoreactive for C-terminal sequence of β-amyloid protein. Neurosci Lett 1996, 206:169-172
49. Martin LJ, Pardo CA, Cork LC, Price DC: Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 1994, 145:1358-1381
50. Pike CJ, Overman MJ, Cotman CW: Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro. J Biol Chem 1995, 270:23895-23898